Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.64 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.64 |
| ▸ | ESR1 | P03372 | 2/20 | 0.62 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | F13A1 | P00488 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | HTR1A | P08908 | 1/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | HTR3A | P46098 | 1/20 | 0.52 |
| ▸ | BACE1 | P56817 | 1/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8576229 | 0.98 | TMEM97 (0.61) | TMEM97SIGMAR1ESR1ESR2KDM4E | |
| SCHEMBL7381628 | 0.82 | TMEM97 (0.67) | TMEM97SIGMAR1ESR1ESR2KDM4E | |
| SCHEMBL29690338 | 0.78 | TMEM97 (0.61) | TMEM97SIGMAR1ESR1ESR2KDM4E | |
| SCHEMBL20831067 | 0.78 | TMEM97 (0.61) | TMEM97SIGMAR1ESR1ESR2KDM4E | |
| SCHEMBL29260565 | 0.78 | GFER (0.59) | TMEM97SIGMAR1KDM4ECA2SLC6A2 | |
| SCHEMBL23664561 | 0.78 | IDO1 (0.40) | TMEM97SIGMAR1ESR1ESR2KDM4E | |
| SCHEMBL274906 | 0.78 | TMEM97 (1.00) | TMEM97SIGMAR1ESR1ESR2KDM4E | |
| SCHEMBL21340678 | 0.78 | SIGMAR1 (0.40) | TMEM97SIGMAR1CA2TAAR1CYP2D6 | |
| SCHEMBL13182899 | 0.78 | TAAR1 (0.50) | TMEM97SIGMAR1KDM4EF13A1ALDH1A1 | |
| SCHEMBL15701213 | 0.78 | TMEM97 (0.61) | TMEM97SIGMAR1ESR1ESR2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1750126-B1 | METHOD AND APPARATUS FOR ANALYZING AMINOFUNCTIONAL COMPOUND | AJINOMOTO KK (JP) | 2015-09-16 | — | — | EP | claimed |
| EP-1692096-B1 | HYDROXYLAMINE DERIVATIVES | NEWRON PHARM SPA (IT) | 2013-04-03 | — | — | EP | claimed |
| US-20100197799-A1 | HYDROXYLAMINE DERIVATIVES | NEWRON PHARMACEUTICALS S.P.A. (IT) | 2010-08-05 | — | — | US | claimed |
| CN-1732028-B | Device for aspirating, irrigating and cleansing wounds | SMITH & NEPHEW | 2010-04-21 | — | — | CN | claimed |
| US-7572776-B2 | N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use | YU RUEY J | 2009-08-11 | — | — | US | claimed |
| JP-2009526755-A | — | — | 2009-07-23 | — | — | JP | claimed |
| CN-101395164-A | N- (phosphonoalkyl) -amino acids, derivatives and compositions thereof, and methods of use | SCOTT EUGENE J VAN YU RUEY J (US) | 2009-03-25 | — | — | CN | claimed |
| US-7494815-B2 | Method and apparatus for analyzing compounds with amino group | AJINOMOTO CO., INC. (JP) | 2009-02-24 | — | — | US | claimed |
| US-20080306025-A1 | N-(PHOSPHONOALKYL)-AMINO ACIDS, DERIVATIVES THEREOF AND COMPOSITIONS AND METHODS OF USE | YU RUEY J | 2008-12-11 | — | — | US | claimed |
| EP-1979366-A2 | N-(PHOSPHONOALKYL)-AMINO ACIDS, DERIVATIVES THEREOF AND COMPOSITIONS AND METHODS OF USE | Yu, Ruey J. (US) | 2008-10-15 | — | — | EP | claimed |
| US-20070269899-A1 | METHOD AND APPARATUS FOR ANALYZING COMPOUNDS WITH AMINO GROUP | AJINOMOTO CO. INC. (JP) | 2007-11-22 | — | — | US | claimed |
| WO-2007082206-A2 | N-(PHOSPHONOALKYL)-AMINO ACIDS, DERIVATIVES THEREOF AND COMPOSITIONS AND METHODS OF USE | YU RUEY J (US) | 2007-07-19 | — | — | WO | claimed |
| US-20070161543-A1 | N-(PHOSPHONOALKYL)-AMINO ACIDS, DERIVATIVES THEREOF AND COMPOSITIONS AND METHODS OF USE | YU RUEY J | 2007-07-12 | — | — | US | claimed |
| US-20070049643-A1 | Hydroxylamine derivatives | VICURON PHARMACEUTICALS INC. | 2007-03-01 | — | — | US | claimed |
| EP-1750126-A1 | METHOD AND APPARATUS FOR ANALYZING AMINOFUNCTIONAL COMPOUND | Ajinomoto Co., Inc. (JP) | 2007-02-07 | — | — | EP | claimed |
| EP-1692096-A1 | HYDROXYLAMINE DERIVATIVES | Newron Pharmaceuticals S.p.A. (IT) | 2006-08-23 | — | — | EP | claimed |
| CN-1732028-A | Device for aspirating, irrigating and cleansing wounds | SMITH & NEPHEW (GB) | 2006-02-08 | — | — | CN | claimed |
| WO-2005058800-A1 | HYDROXYLAMINE DERIVATIVES | NEWRON PHARMACEUTICALS S.P.A. (IT) | 2005-06-30 | — | — | WO | claimed |
| EP-1541547-A1 | Hydroxylamine derivatives | Newron Pharmaceuticals S.p.A. (IT) | 2005-06-15 | — | — | EP | claimed |
| CN-122038251-A | Preparation method and application of microorganism for producing 1-phenethyl isoquinoline | 中国科学院分子植物科学卓越创新中心 | 2026-05-15 | — | — | CN | disclosed |
| CN-119774557-A | Composite heterogeneous nano material and preparation method and application thereof | 长江师范学院 | 2025-04-08 | — | — | CN | disclosed |
| US-20250076325-A1 | ARTIFICIAL HAPTEN AND ARTIFICIAL ANTIGEN OF FENTANYL, AND PREPARATION METHOD AND APPLICATION THEREOF | HANGZHOU ALLTEST BIOTECH CO LTD (CN) | 2025-03-06 | — | — | US | disclosed |
| CN-115215752-B | Method and equipment for preparing dopamine substances from papermaking black liquor | 南京林业大学 | 2024-10-22 | — | — | CN | disclosed |
| CN-117143338-A | Polydopamine-halloysite composite material, preparation method and application thereof | 北京理工大学 | 2023-12-01 | — | — | CN | disclosed |
| US-20220226310-A1 | Bio-Based Medicines and Methods of Increasing Patient Compliance | RDE PHARMA | 2022-07-21 | — | — | US | disclosed |
| EP-2298281-B1 | Infusion and injection solution of Levodopa | DIZLIN PHARMACEUTICALS AB (SE) | 2019-04-24 | — | — | EP | disclosed |
| CN-107455625-A | A kind of nutrient for plants beverage and its preparation technology with antifatigue weight losing function | 宁夏五行科技有限公司 | 2017-12-12 | — | — | CN | disclosed |
| CN-107439866-A | Matrimony vine chickpea plant nutrients beverage and its preparation technology | 宁夏信安永达科技有限公司 | 2017-12-08 | — | — | CN | disclosed |
| CN-105092753-B | The application of combined amine metabolic markers and test kit | 中国科学院大连化学物理研究所 | 2016-09-07 | — | — | CN | disclosed |
| US-9248113-B2 | Infusion and injection solution of Levodopa | DIZLIN MEDICAL DESIGN AB (SE) | 2016-02-02 | — | — | US | disclosed |
| US-20150346219-A1 | METHODS OF DETERMINING LEVELS OF FREE AMINO ACIDS AND DIPEPTIDES AND DIAGNOSING ALZHEIMER'S DISEASE | HUNTINGTON MEDICAL RES INST (US) | 2015-12-03 | — | — | US | disclosed |
| CN-105092753-A | Application of combination amine metabolism marker and kit and detection method thereof | DALIAN CHEMICAL PHYSICS INST | 2015-11-25 | — | — | CN | disclosed |
| EP-1750126-B1 | METHOD AND APPARATUS FOR ANALYZING AMINOFUNCTIONAL COMPOUND | AJINOMOTO KK (JP) | 2015-09-16 | — | — | EP | disclosed |
| EP-1773297-B1 | INFUSION AND INJECTION SOLUTION OF LEVODOPA | DIZLIN MEDICAL DESIGN AB (SE) | 2015-01-14 | — | — | EP | disclosed |
| US-20140308753-A1 | METHODS OF DETERMINING LEVELS OF FREE AMINO ACIDS AND DIPEPTIDES AND DIAGNOSING ALZHEIMER'S DISEASE | HUNTINGTON MEDICAL RESEARCH INSTITUTES (US) | 2014-10-16 | — | — | US | disclosed |
| US-20140221489-A1 | Infusion and Injection Solution of Levodopa | DIZLIN MEDICAL DESIGN AB (SE) | 2014-08-07 | — | — | US | disclosed |
| US-20140187593-A1 | DIAGNOSTIC TEST AND TREATMENT FOR A NEUROLOGICAL DISORDER | MINASSIAN BERGE (CA) | 2014-07-03 | — | — | US | disclosed |
| US-8735382-B2 | Infusion and injection solution of levodopa | DIZLIN MEDICAL DESIGN AB (SE) | 2014-05-27 | — | — | US | disclosed |
| CN-101525330-B | Phosphopyridoxal intermediates, preparation method of same, application of same, and method for preparing phosphopyridoxal therefrom | SHANGHAI INST PHARM INDUSTRY | 2014-01-15 | — | — | CN | disclosed |
| US-20140005269-A1 | POLYMERIC MATRIX OF POLYMER-LIPID NANOPARTICLES AS A PHARMACEUTICAL DOSAGE FORM | UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURG (ZA) | 2014-01-02 | — | — | US | disclosed |
| EP-1692096-B1 | HYDROXYLAMINE DERIVATIVES | NEWRON PHARM SPA (IT) | 2013-04-03 | — | — | EP | disclosed |
| CN-101525331-B | Phosphopyridoxal intermediates, preparation method of same, application of same, and method for preparing phosphopyridoxal therefrom | SHANGHAI INST PHARM INDUSTRY | 2012-11-07 | — | — | CN | disclosed |
| US-8153784-B2 | Imaging of enzyme activity | THE GENERAL HOSPITAL CORPORATION (US) | 2012-04-10 | — | — | US | disclosed |
| US-20100247463-A1 | N-(PHOSPHONOALKYL)-AMINO ACIDS, DERIVATIVES THEREOF AND COMPOSITIONS AND METHODS OF USE | YU RUEY J | 2010-09-30 | — | — | US | disclosed |
| US-20100233316-A1 | FERMENTED BUBBLE DRINK WITH FUNCTIONALITY | KWON TAE-GOOK | 2010-09-16 | — | — | US | disclosed |
| US-7776844-B2 | N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use | YU RUEY J | 2010-08-17 | — | — | US | disclosed |
| US-20100197799-A1 | HYDROXYLAMINE DERIVATIVES | NEWRON PHARMACEUTICALS S.P.A. (IT) | 2010-08-05 | — | — | US | disclosed |
| US-7763751-B2 | Hydroxylamine derivatives | NEWRON PHARMACEUTICALS S.P.A. (IT) | 2010-07-27 | — | — | US | disclosed |
| US-20100021582-A1 | Fermented bubble drink with functionality | KWON TAE-GOOK | 2010-01-28 | — | — | US | disclosed |
| CN-101525331-A | Phosphopyridoxal intermediates, preparation method of same, application of same, and method for preparing phosphopyridoxal therefrom | SHANGHAI INST PHARM INDUSTRY (CN) | 2009-09-09 | — | — | CN | disclosed |
| CN-101525330-A | Phosphopyridoxal intermediates, preparation method of same, application of same, and method for preparing phosphopyridoxal therefrom | SHANGHAI INST PHARM INDUSTRY (CN) | 2009-09-09 | — | — | CN | disclosed |
| US-20090208499-A1 | N-(Phosphonoalkyl)-Amino Acids, Derivatives Thereof and Compositions and Methods of Use | YU RUEY J | 2009-08-20 | — | — | US | disclosed |
| US-7572776-B2 | N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use | YU RUEY J | 2009-08-11 | — | — | US | disclosed |
| CN-101394758-A | Fermented bubble drink with functionality | KWON TAE GOOK (KR) | 2009-03-25 | — | — | CN | disclosed |
| CN-101395164-A | N- (phosphonoalkyl) -amino acids, derivatives and compositions thereof, and methods of use | SCOTT EUGENE J VAN YU RUEY J (US) | 2009-03-25 | — | — | CN | disclosed |
| US-7494815-B2 | Method and apparatus for analyzing compounds with amino group | AJINOMOTO CO., INC. (JP) | 2009-02-24 | — | — | US | disclosed |
| US-20080306025-A1 | N-(PHOSPHONOALKYL)-AMINO ACIDS, DERIVATIVES THEREOF AND COMPOSITIONS AND METHODS OF USE | YU RUEY J | 2008-12-11 | — | — | US | disclosed |
| US-20080255235-A1 | Inhibitor of a Levodopa-metabolising enzyme, a buffer, a sugar, an acid; Parkinson's disease | DIZLIN MEDICAL DESIGN AB (SE) | 2008-10-16 | — | — | US | disclosed |
| EP-1979366-A2 | N-(PHOSPHONOALKYL)-AMINO ACIDS, DERIVATIVES THEREOF AND COMPOSITIONS AND METHODS OF USE | Yu, Ruey J. (US) | 2008-10-15 | — | — | EP | disclosed |
| US-7429575-B2 | N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use | YU RUEY J | 2008-09-30 | — | — | US | disclosed |
| EP-1516892-B1 | POLYESTER COMPOSITION AND PACKAGING MATERIAL COMPRISING THE SAME | TOYO BOSEKI (JP) | 2008-09-10 | — | — | EP | disclosed |
| US-20080044827-A1 | Imaging of Enzyme Activity | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-02-21 | — | — | US | disclosed |
| US-20070269899-A1 | METHOD AND APPARATUS FOR ANALYZING COMPOUNDS WITH AMINO GROUP | AJINOMOTO CO. INC. (JP) | 2007-11-22 | — | — | US | disclosed |
| CN-100334151-C | Polyester composition and packaging material comprising the same | TOYO BOSEKI IND (JP) | 2007-08-29 | — | — | CN | disclosed |
| WO-2007082206-A2 | N-(PHOSPHONOALKYL)-AMINO ACIDS, DERIVATIVES THEREOF AND COMPOSITIONS AND METHODS OF USE | YU RUEY J (US) | 2007-07-19 | — | — | WO | disclosed |
| US-20070161543-A1 | N-(PHOSPHONOALKYL)-AMINO ACIDS, DERIVATIVES THEREOF AND COMPOSITIONS AND METHODS OF USE | YU RUEY J | 2007-07-12 | — | — | US | disclosed |
| EP-1773297-A1 | INFUSION AND INJECTION SOLUTION OF LEVODOPA | Dizlin Medical Design AB (SE) | 2007-04-18 | — | — | EP | disclosed |
| US-20070049643-A1 | Hydroxylamine derivatives | VICURON PHARMACEUTICALS INC. | 2007-03-01 | — | — | US | disclosed |
| EP-1750126-A1 | METHOD AND APPARATUS FOR ANALYZING AMINOFUNCTIONAL COMPOUND | Ajinomoto Co., Inc. (JP) | 2007-02-07 | — | — | EP | disclosed |
| EP-1692096-A1 | HYDROXYLAMINE DERIVATIVES | Newron Pharmaceuticals S.p.A. (IT) | 2006-08-23 | — | — | EP | disclosed |
| US-20060094765-A1 | Use of a sri and vitamin b6 for the treatment of neurological and mental disorders | PANTARHEI BIOSCIENCE B.V. (NL) | 2006-05-04 | — | — | US | disclosed |
| WO-2006014530-A2 | IMAGING OF ENZYME ACTIVITY | THE GENERAL HOSPITAL CORPORATION (US) | 2006-02-09 | — | — | WO | disclosed |
| WO-2006006929-A1 | INFUSION AND INJECTION SOLUTION OF LEVODOPA | DIZLIN MEDICAL DESIGN AB (SE) | 2006-01-19 | — | — | WO | disclosed |
| US-20050222345-A1 | Polyester composition and polyester packaging material comprising the same | TOKYO BOSEKI KABUSHIKI KAISHA (JP) | 2005-10-06 | — | — | US | disclosed |
| CN-1659231-A | Polyester composition and packaging material comprising the same | TOYO BOSEKI (JP) | 2005-08-24 | — | — | CN | disclosed |
| WO-2005058800-A1 | HYDROXYLAMINE DERIVATIVES | NEWRON PHARMACEUTICALS S.P.A. (IT) | 2005-06-30 | — | — | WO | disclosed |
| EP-1545487-A1 | USE OF A SRI AND VITAMIN B6 FOR THE TREATMENT OF NEUROLOGICAL AND MENTAL DISORDERS | Pantarhei Bioscience B.V. (NL) | 2005-06-29 | — | — | EP | disclosed |
| EP-1541547-A1 | Hydroxylamine derivatives | Newron Pharmaceuticals S.p.A. (IT) | 2005-06-15 | — | — | EP | disclosed |
| EP-1516892-A1 | POLYESTER COMPOSITION AND PACKAGING MATERIAL COMPRISING THE SAME | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 2005-03-23 | — | — | EP | disclosed |
| EP-1326523-A4 | IMAGING OF ENZYMATIC ACTIVITY | GEN HOSPITAL CORP (US) | 2005-01-05 | — | — | EP | disclosed |
| US-20040241096-A1 | Detect enzyme activity in sample; incubation target tissue; detect amplification in sample | THE GENERAL HOSPITAL CORPORATION, A MASSACHUSETTS CORPORATION | 2004-12-02 | — | — | US | disclosed |
| US-6737247-B2 | DETECTING ENZYMATIC ACTIVITY IN SAMPLE; OBTAIN SUBSTRATE, INCUBATE WITH TARGET TISSUE, DETECT AMPLIFIED RELAXIVITY OF SAMPLE, EVALUATE ENZYMATIC ACTIVITY SAMPLE | THE GENERAL HOSPITAL CORPORATION | 2004-05-18 | — | — | US | disclosed |
| WO-2004022043-A1 | USE OF A SRI AND VITAMIN B6 FOR THE TREATMENT OF NEUROLOGICAL AND MENTAL DISORDERS | PANTARHEI BIOSCIENCE B.V. (NL) | 2004-03-18 | — | — | WO | disclosed |
| CN-1132633-C | Pharmaceutical composition containing gelling agents in the form of alkylamides of di-and tri-carboxylic acids | PROCTER & GAMBLE (US) | 2003-12-31 | — | — | CN | disclosed |
| EP-1326523-A2 | IMAGING OF ENZYMATIC ACTIVITY | THE GENERAL HOSPITAL CORPORATION (US) | 2003-07-16 | — | — | EP | disclosed |
| WO-2002032291-A9 | IMAGING OF ENZYMATIC ACTIVITY | GEN HOSPITAL CORP (US) | 2003-04-17 | — | — | WO | disclosed |
| WO-2002100404-A2 | PYRIDOXAL IN COMBINATION WITH SEROTONIN RE-UPTAKE INHIBITOR FOR THE TREATMENT OF HOT FLUSHES | PANTARHEI BIOSCIENCE B.V. (NL) | 2002-12-19 | — | — | WO | disclosed |
| EP-1266659-A1 | Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes | Pantarhei Bioscience B.V. (NL) | 2002-12-18 | — | — | EP | disclosed |
| US-20020127629-A1 | Imaging of enzymatic activity | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-09-12 | — | — | US | disclosed |
| WO-2002032291-A2 | IMAGING OF ENZYMATIC ACTIVITY | THE GENERAL HOSPITAL CORPORATION (US) | 2002-04-25 | — | — | WO | disclosed |
| EP-1142563-A1 | HAIR DYE COMPOSITIONS | Lion Corporation (JP) | 2001-10-10 | — | — | EP | disclosed |
| CN-1245435-A | Pharmaceutical compositions containing gellants in form of alkyl amides of di- and tri-carboxylic acids | PROCTER & GAMBLE (US) | 2000-02-23 | — | — | CN | disclosed |
| US-5711932-A | APPLYING TO NERVE CORD OF DROSOPHILA, CHOLINERGIC AGENTS | HIRSH JAY (US) | 1998-01-27 | — | — | US | disclosed |
| US-5510260-A | Prolactin secreting cell line and method of obtaining the same | UNVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 1996-04-23 | — | — | US | disclosed |
| US-5430189-A | Process for preparing substituted and unsubstituted arylalkylamines | HOECHST CELANESE CORPORATION (US) | 1995-07-04 | — | — | US | disclosed |
| US-5319142-A | Process for preparing substituted and unsubstituted arylalkylamines | HOECHST CELANESE CORPORATION (US) | 1994-06-07 | — | — | US | disclosed |
| EP-0564212-A2 | Process for the preparation of arylethylamines and substituted arylethylamines | HOECHST CELANESE CORPORATION (US) | 1993-10-06 | — | — | EP | disclosed |
| EP-0564213-A2 | Process for the preparation of arylethylamines and substituted arylethylamines | HOECHST CELANESE CORPORATION (US) | 1993-10-06 | — | — | EP | disclosed |
| US-5220067-A | Process for the preparation of arylethylamines and substituted arylethylamines | HOECHST CELANESE CORPORATION (US) | 1993-06-15 | — | — | US | disclosed |
| US-5220066-A | Process for the preparation of arylethylamines and substituted arylethylamines | HOECHST CELANESE CORPORATION (US) | 1993-06-15 | — | — | US | disclosed |
| US-5175368-A | Hydrogenating aryl alpha-oximinoalkyl ketones in aqueous medium containing hydrochlroic acid, recovering salt | HOECHST CELANESE CORPORATION (US) | 1992-12-29 | — | — | US | disclosed |
| EP-0491557-A1 | Process for the preparation of arylalkylamines and substituted arylalkylamines | HOECHST CELANESE CORPORATION (US) | 1992-06-24 | — | — | EP | disclosed |
| EP-0481705-A1 | Process for the preparation of arylalkylamines and substituted arylalkylamines | HOECHST CELANESE CORPORATION (US) | 1992-04-22 | — | — | EP | disclosed |
| EP-0320194-B1 | ABSORBENT FOR FREE HEMOGLOBIN | Japan Medical Supply Co., Ltd. (JP) | 1992-02-26 | — | — | EP | disclosed |
| US-5041669-A | Reacting alkyl aryl ketones with alkyl nitrites, extracting product, catalytically hydrogenating/reducing in nonaqueous acid mixture | HOECHST CELANESE CORPORATION (US) | 1991-08-20 | — | — | US | disclosed |
| US-4952322-A | USING WATER INSOLUBLE POROUS CARRIER WITH PHENYL OR PHENOL GROUPS ON SURFACE | JAPAN MEDICAL SUPPLY CO., LTD. (JP) | 1990-08-28 | — | — | US | disclosed |
| EP-0320194-A1 | Absorbent for free hemoglobin | Japan Medical Supply Co., Ltd. (JP) | 1989-06-14 | — | — | EP | disclosed |
| US-4837115-A | BLEND WITH POLYAMIDE; FOOD STORAGE | TOYO SEIKAN KAISHA, LTD. (JP) | 1989-06-06 | — | — | US | disclosed |
| US-4837115-A | BLEND WITH POLYAMIDE; FOOD STORAGE | TOYO SEIKAN KAISHA, LTD. (JP) | 1989-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197799-A1 | HYDROXYLAMINE DERIVATIVES | C9, C1S, HTT | TMEM97 909/4885SIGMAR1 139/4885ESR1 3794/4885 |
| US-20080044827-A1 | Imaging of Enzyme Activity | GBA3, BCHE, MGAM | TMEM97 2007/4885SIGMAR1 3382/4885ESR1 3488/4885 |
| US-20220226310-A1 | Bio-Based Medicines and Methods of Increasing Patient Compliance | PAH, BPGM, TPMT | TMEM97 2564/4885SIGMAR1 2077/4885ESR1 1329/4885 |
| US-20020127629-A1 | Imaging of enzymatic activity | MMP1, ENGASE, MMP2 | TMEM97 3385/4885SIGMAR1 890/4885ESR1 1948/4885 |
| US-20250076325-A1 | ARTIFICIAL HAPTEN AND ARTIFICIAL ANTIGEN OF FENTANYL, AND PREPARATION METHOD AND APPLICATION THEREOF | CD69, HLA-C, HLA-A | TMEM97 1053/4885SIGMAR1 267/4885ESR1 1342/4885 |
| US-20040241096-A1 | Detect enzyme activity in sample; incubation target tissue; detect amplification in sample | MMP1, ENGASE, MMP2 | TMEM97 3457/4885SIGMAR1 1266/4885ESR1 887/4885 |
| US-20070049643-A1 | Hydroxylamine derivatives | C9, C1S, HTT | TMEM97 922/4885SIGMAR1 126/4885ESR1 3732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.